Impax Laboratories (IPXL) Misses Q3 EPS by 2c

November 9, 2016 7:02 AM EST
Get Alerts IPXL Hot Sheet
Trade IPXL Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Impax Laboratories (NASDAQ: IPXL) reported Q3 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $228 million versus the consensus estimate of $234.87 million.

For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment